R. Schafer et al., MULTIPLE INTRACELLULAR PATHWAYS INTERFERE WITH THE ACTIVATION OF A CPP32-LIKE PROTEASE INDUCED BY SERUM DEPRIVATION OF AKR-2B CELLS, Experimental cell research, 240(1), 1998, pp. 28-39
As previously described, confluent AKR-2B fibroblasts rapidly disinteg
rate upon removal of serum. Platelet-derived growth factor isoforms AB
or BE (PDGF AB, -BB) added immediately after serum deprivation caused
complete survival of the cells without initiating proliferation (Simm
ef al., 1994, J. Cell. Physiol 160, 295), Here the role of cAMP as a
protective agent was investigated by using forskolin or 8-Br-cAMP. Bot
h reagents afforded high cellular protection. The phorbolester TPA, an
activator of protein kinase C isoforms, also exerted a high protectio
n against cell. death (ED50 = 7 nM). Unexpectedly colchicine (ED50 = 1
.5 mu M) an inhibitor of tubulin polymerization also protected cells f
rom death. The protective effects of PDGF-BB and TPA were dependent on
protein synthesis as indicated by their complete suppression by cyclo
heximide (CHx). Surprisingly, forskolin and 8-Br-cAMP remained effecti
ve even in the presence of CHx. Detailed studies of several signalling
pathways were performed, These investigations showed no interference
between PBGF-BB and cAMP-dependent pathways at the early stage of sign
al transduction, As previously described, the ICE-like protease inhibi
tor tyr-val-ala-asp-chloromethylketone (YVAD-cmk) protected cells from
death (Simm et al., 1997, J, Cell Sci. 110, 819-828). As shown here,
a substantial protection was also achieved by the addition of two othe
r caspase inhibitors: asp-glu-val-asp-aldehyde (DEVD-cho; ED50 = 100 m
u M) and benzoylcarbonyl-asp-glu-val-asp-chloromethylketone (Z-D3EVD-c
mk; ED50 = 100 mu M). The activity of caspases was studied using eithe
r tyr-val-ala-asp-aminomethylcoumarine (YVAD-amc) or asp-glu-val-asp-a
minomethylcoumarine (DEVD-amc) as substrates. There was no activation
of a YVADase, whereas as pronounced increase in DEVDase activity was f
ound with a maximum 3 h after serum removal. Cross competition experim
ents in vitro showed that the latter activity is inhibited also by low
concentrations of YVAD-cmk (300-600 nM), suggesting that both inhibit
ors inactivated the same target protease. Remarkably all tested protec
tive reagents lead to an inhibition of the DEVDase activity in intact
cells. Since these reagents act via distinct intracellular pathways, t
he existence of a regulatory element upstream of the DEVDase is propos
ed which integrates signals from a variety of pathways. (C) 1998 Acade
mic Press.